Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin therapy for neurologic disorders.

R Tim1, J M Massey

  • 1Duke University Medical Center, Durham, NC 27710.

Postgraduate Medicine
|May 1, 1992
PubMed
Summary

Botulinum toxin injections offer effective treatment for focal dystonias like blepharospasm and torticollis. Ongoing research explores its use for other conditions requiring targeted muscle weakening.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of risk score analysis to low-coverage whole genome sequencing data for the noninvasive detection of trisomy 21, trisomy 18, and trisomy 13.

Prenatal diagnosis·2015
Same author

Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

Journal of autoimmunity·2014
Same author

Is the decremental pattern in Lambert-Eaton syndrome different from that in myasthenia gravis?

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2013
Same author

Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties.

Neurology·2010
Same author

Predictive value of single-fiber electromyography in the extensor digitorum communis muscle of patients with ocular myasthenia gravis: a retrospective study.

Journal of clinical neuromuscular disease·2008
Same author

Invited article: The ABPN maintenance of certification program for neurologists: past, present, and future.

Neurology·2008

Area of Science:

  • Neuroscience
  • Pharmacology
  • Medical Therapeutics

Background:

  • Botulinum toxin is a potent neurotoxin with investigated therapeutic applications over the past two decades.
  • The toxin induces chemical denervation, leading to muscle atrophy and weakness.

Purpose of the Study:

  • To review the established and emerging therapeutic uses of botulinum toxin.
  • To highlight its efficacy in treating focal dystonias and explore potential applications in other neuromuscular disorders.

Main Methods:

  • Review of studies investigating the therapeutic applications of botulinum toxin.
  • Analysis of its mechanism of action (chemical denervation) and clinical outcomes.

Main Results:

  • Botulinum toxin injections are proven effective for focal dystonias, including blepharospasm, hemifacial spasm, and torticollis.
  • Evidence supports its role in managing conditions characterized by focal muscle overactivity.

Conclusions:

  • Botulinum toxin is an established therapy for specific focal dystonias.
  • Further investigation is warranted for its application in disorders such as anismus, detrusor-sphincter dyssynergia, and writer's cramp.

Related Experiment Videos